Unity Biotechnology, Inc. Operating Lease Right-of-Use Assets
Unity Biotechnology, Inc. had Operating Lease Right-of-Use Assets of $8.46 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-04-22
- 2025-03-31: Operating Lease, Right-of-Use Asset $8.46M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $8.90M.
- 2024-09-30: Operating Lease, Right-of-Use Asset $11.36M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $11.90M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-03-31 | $8.46M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $8.90M 10-Q · filed 2025-04-22 |
| 2024-09-30 | $11.36M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $11.90M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $12.44M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $12.98M 10-K · filed 2025-03-07 |
| 2023-09-30 | $13.52M 10-K · filed 2024-04-15 |
| 2023-06-30 | $18.06M 10-K · filed 2024-04-15 |
| 2023-03-31 | $18.56M 10-K · filed 2024-04-15 |
| 2022-12-31 | $19.04M 10-K · filed 2024-04-15 |
| 2022-09-30 | $19.52M 10-K · filed 2024-04-15 |
| 2022-06-30 | $20.12M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $20.71M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $21.29M 10-K · filed 2023-03-15 |
| 2021-09-30 | $21.86M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $22.42M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $22.97M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $23.51M 10-K · filed 2022-03-15 |
| 2020-09-30 | $24.33M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $24.89M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $25.44M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-23 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-23 |